Beyond the Surface: Tailored Solutions for Tear Evaporation in Meibomian Gland Dysfunction : Episode 8

Clinical Case Scenario: Management Strategies for MGD and Key Takeaways

July 23, 2024

By Jessilin Quint, OD, MBA, MS, FAAO
Selina R. McGee, OD, FAAO, Dipl ABO

Opinion

Video

Focusing on the care of patients with MGD, Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, provide key takeaways on treatment practices.

EP: 1.Overview of MGD and Its Causes

EP: 2.Differentiating Aqueous vs Evaporative Dry Eye

EP: 3.Long-Term Consequences of Untreated MGD

EP: 4.Factors to Consider in Treatment Selection for MGD

EP: 5.Managing Evaporative Dry Eye with New FDA-Approved Therapy

EP: 6.Differentiating Between the Semi-Fluorinated Alkane-Based Therapies for Dry Eye

EP: 7.Combining In-Office and At-Home Therapies

EP: 8.Clinical Case Scenario: Management Strategies for MGD and Key Takeaways

Video content above is prompted by the following question:

What advice do you have for clinicians on diagnosing and treating meibomian gland dysfunction (MGD)?

Recent Videos

In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.

Dr Pedram Hamrah

Diabetic eye care expert A. Paul Chous, OD, MA, FAAO, shares insights on patient care and research

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

Terms & Conditions

Do not sell my Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.